MOLECULAR MECHANISMS REGULATING CD19, CD20 AND CD22 GENE-EXPRESSION

被引：71

作者：

KEHRL, JH

RIVA, A

WILSON, GL

THEVENIN, C

机构：

[1] John H. Kehrl, Agostino Riva, Gaye Lynn Wilson and Claire Thévenin are in the Section of B Cell Molecular Immunology, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda

来源：

IMMUNOLOGY TODAY | 1994年 / 15卷 / 09期

关键词：

D O I：

10.1016/0167-5699(94)90273-9

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The CD19, CD20 and CD22 genes encode transmembrane proteins that are of vital importance to B-cell function. Similar to the immunoglobulin (Ig) genes, they are expressed in a lineage-specific and developmentally regulated manner. Here, John Kehrl and colleagues describe how an understanding of the transcriptional regulation of the CD19, CD20 and CD22 genes is leading to valuable insights into some of the important molecular events that occur in B-cell development and differentiation.

引用

页码：432 / 436

页数：5

共 50 条

[1] DOWNREGULATION OF CD19, CD20 AND CD22 SURFACE EXPRESSION ON MANTLE CELL LYMPHOMA BY LENALIDOMIDE
Eve, E.
Richardson, J.
Rule, S.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 608 - 609
[2] DEVELOPMENT OF HUMAN B-CELL LINES DEFICIENT IN CD19, CD20, OR CD22
WILSON, GL
RIVA, A
KEHRL, JH
JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A99 - A99
[3] Human basophils express CD22 without expression of CD19
Han, KJ
Kim, Y
Lee, J
Lim, J
Lee, KY
Kang, CS
Kim, WI
Kim, BK
Shim, SI
Kim, SM
CYTOMETRY, 1999, 37 (03): : 178 - 183
[4] Heterogeneity of surface CD19 and CD22 expression in B lymphoblastic leukemia
Rosenthal, Jaclyn
Naqvi, Ammar S.
Luo, Minjie
Wertheim, Gerald
Paessler, Michele
Thomas-Tikhonenko, Andrei
Rheingold, Susan R.
Pillai, Vinodh
AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (11) : E352 - E355
[5] MOLECULAR MECHANISMS REGULATING CD19 GENE-TRANSCRIPTION
RIVA, A
WILSON, GL
KEHRL, JH
CLINICAL RESEARCH, 1994, 42 (02): : A123 - A123
[6] Levels of expression of CD19 and CD20 in chronic B cell leukaemias
Ginaldi, L
De Martinis, M
Matutes, E
Farahat, N
Morilla, R
Catovsky, D
JOURNAL OF CLINICAL PATHOLOGY, 1998, 51 (05) : 364 - 369
[7] Alpha-radioimmunotherapy with 213Bi-labelled CD19, CD20 and CD22 antibodies for B-cell lymphoma.
Wilmes, A
Voso, MT
Apostoldis, C
Molinet, R
Moldenhauser, G
Wesch, H
van Kaick, G
Koch, L
Haas, R
BLOOD, 1998, 92 (10) : 416A - 416A
[8] Increased expression of CD20 and CD45 and diminished expression of CD19 are features of follicular lymphoma
Liu, Qingyan
Weaver, Linda S.
Liewehr, David
Venzon, David
Stetler-Stevenson, Maryalice
Yuan, Constance M.
PATHOLOGY AND LABORATORY MEDICINE INTERNATIONAL, 2013, 5 : 21 - 30
[9] CD19 and CD20 expression in chronic B-cell leukaemias.
Ginaldi, L
DeMartinis, M
Matutes, E
Farahat, N
Morilla, R
Catovsky, D
BLOOD, 1997, 90 (10) : 4090 - 4090
[10] Bicistronic CAR Constructs for Dual CD19 and CD20 Targeting
Yang, Shicheng
Lam, Norris
Kochenderfer, James N.
MOLECULAR THERAPY, 2020, 28 (04) : 149 - 150

← 1 2 3 4 5 →